RHC.AX · ASX · Healthcare
Ramsay Health Care Limited
Also onShortfallConsensus DriftCrosscheck
Implied value per share
AUD 9.16
Market price
AUD 55.39
Implied upside
-83.5%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (AUD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | AUD 19.5bn | AUD 21.6bn | AUD 23.9bn | AUD 26.4bn | AUD 29.2bn | +10.5% |
| EBIT | AUD 754.6m | AUD 834.2m | AUD 922.2m | AUD 1.0bn | AUD 1.1bn | +10.5% |
| NOPAT | AUD 528.2m | AUD 583.9m | AUD 645.5m | AUD 713.6m | AUD 788.9m | +10.5% |
| Add depreciation & amortisation | AUD 1.3bn | AUD 1.4bn | AUD 1.6bn | AUD 1.8bn | AUD 1.9bn | +10.5% |
| Less capital expenditure | AUD -938.4m | AUD -1.0bn | AUD -1.1bn | AUD -1.3bn | AUD -1.4bn | +10.5% |
| Less increase in working capital | AUD 837.5k | AUD 925.8k | AUD 1.0m | AUD 1.1m | AUD 1.3m | -10.5% |
| Free cashflow to firm | AUD 892.5m | AUD 986.6m | AUD 1.1bn | AUD 1.2bn | AUD 1.3bn | +10.5% |
| Discount factor | 0.9675 | 0.9058 | 0.8479 | 0.7938 | 0.7431 | - |
| Present value | AUD 863.5m | AUD 893.6m | AUD 924.8m | AUD 957.1m | AUD 990.5m | +3.5% |
| Present Value Of The Forecast | AUD 4.6bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 5.35% | Australian Government 10-year (RBA F2) |
| Equity risk premium | 6.00% | Market assumption |
| Beta | 0.732 | Reported 0.600, pulled toward 1.0 (Blume) |
| Cost of equity | 9.74% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.35% | Floored at the risk-free rate (implied cost of debt was lower) |
| Market capitalisation | AUD 12.8bn | 51.3% of capital |
| Total debt | AUD 12.1bn | 48.7% of capital, book value as a proxy |
| Tax rate | 30.0% | Effective, capped at statutory |
| WACC | 6.82% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
66% of EV
- Forecast FCFF, final year
- AUD 1.3bn
- Capex at depreciation, working capital in reinvestment
- AUD 788.9m
- Less reinvestment at g/ROIC (36.6% of NOPAT)
- AUD -289.1m
- Capitalised
- AUD 499.8m
- ROIC (WACC floor)
- 6.8%
- Terminal value, undiscounted
- AUD 11.9bn
- Terminal value, discounted
- AUD 8.8bn
- Enterprise value
- AUD 13.4bn
- Less net debt
- AUD 11.3bn
- Equity value
- AUD 2.1bn
Exit at 12.1x EBITDA
86% of EV
- Terminal value, undiscounted
- AUD 37.1bn
- Terminal value, discounted
- AUD 27.6bn
- Enterprise value
- AUD 32.2bn
- Less net debt
- AUD 11.3bn
- Equity value
- AUD 20.9bn
Spread between methods: 163%.
Sensitivity
Value per share (AUD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 4.82% | 30.34 | 30.63 | 30.92 | 31.21 | 31.50 |
| 5.82% | 17.74 | 17.97 | 18.20 | 18.43 | 18.65 |
| 6.82% | 8.79 | 8.97 | 9.16 | 9.35 | 9.54 |
| 7.82% | 2.09 | 2.25 | 2.40 | 2.56 | 2.72 |
| 8.82% | -3.12 | -2.99 | -2.85 | -2.72 | -2.59 |
Outlined: this model. Green text: above today's price of 55.39. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 10.5% | 26.1% | +15.5pp |
| EBIT margin | 3.9% | 7.4% | +3.5pp |
| Discount rate | 6.8% | 4.2% | -2.6pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.